Table 2.
Distribution of neutralizing antibody titers against human adenovirus (HAdV) types in health donors from Guangzhou.
| Neutralizing titer | Viruses, n (%) | P value | |||||
|---|---|---|---|---|---|---|---|
| HAdV-3 | HAdV-7 | HAdV-4 | HAdV-55 | HAdV-14 | HAdV-11 | ||
| < 18 | 172 (61.87) | 226 (81.30) | 238 (85.61) | 257 (92.45) | 253 (91.01) | 263 (94.60) | < 0.001 |
| 18–144 | 64 (23.02) | 33 (11.87) | 16 (5.76) | 10 (3.60) | 20 (7.19) | 13 (4.68) | < 0.001 |
| 145–576 | 18 (6.48) | 12 (4.32) | 7 (2.52) | 3 (1.08) | 4 (1.44) | 2 (0.72) | < 0.001 |
| > 576 | 24 (8.63) | 7 (2.52) | 17 (6.12) | 8 (2.88) | 1 (0.36) | 0 (0) | < 0.001 |
| ≥ 18 | 106 (38.13) | 52 (18.71) | 40 (14.39) | 21 (7.55) | 25 (8.99) | 15 (5.40) | < 0.001 |
P value was assessed by Pearson’s chi-squared test